Single-cell Omics Market to Grow at a CAGR of 6.87% through 2030

Advances In Single-Cell Technologies and Growing Focus On Precision Medicine are expected to drive the Global Single-cell Omics Market growth in the forecast period, 2026-2030 

According to TechSci Research report, “Single-cell Omics Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Single-cell Omics Market stood at USD 1.52 billion in 2024 and is anticipated to reach USD 2.27 Billion by 2030 with a CAGR of 6.87% during the forecast period. 

The integration of artificial intelligence (AI) into single-cell omics analysis is revolutionizing the field, offering transformative solutions to manage and interpret complex datasets with unprecedented efficiency. AI-powered algorithms are enabling researchers to uncover deeper insights by identifying intricate patterns, classifying cell types, and predicting cellular behaviors with remarkable precision. These advancements have streamlined data interpretation, significantly reducing analysis time and costs while enhancing result accuracy. For instance, AI-driven predictive models are reshaping the understanding of disease progression at the single-cell level, paving the way for breakthroughs in precision medicine and targeted therapeutic development.

Machine learning is addressing critical challenges in high-throughput single-cell sequencing, such as error correction and missing data imputation. These advancements are improving the robustness and reproducibility of results, fostering standardization across research institutions. With the global single-cell omics market experiencing rapid growth, AI adoption is becoming a strategic differentiator for companies delivering next-generation analytical solutions. Furthermore, AI-enabled platforms are driving cross-disciplinary innovations by integrating multi-omics datasets for holistic cellular profiling, catalyzing partnerships between technology providers and biotechnology firms to expedite innovation pipelines. This synergy is particularly impactful in drug discovery, personalized medicine, and oncology, where AI accelerates the discovery of actionable insights.

Spatial transcriptomics represents a significant leap forward in the single-cell omics domain, providing the ability to map gene expression while preserving tissue architecture. Unlike traditional methods that dissociate cells, this technology maintains spatial context, offering critical insights into cellular interactions and the microenvironment. Advanced imaging and sequencing innovations have elevated the resolution and throughput of spatial transcriptomics, fueling its adoption across applications in oncology, neuroscience, and developmental biology. Researchers are now leveraging this capability to dissect tumor microenvironments, uncovering mechanisms of cancer progression and resistance to therapy.

To capitalize on this growing demand, leading companies are heavily investing in user-centric spatial transcriptomics platforms, broadening accessibility for laboratories. Strategic collaborations between biotechnology firms and academic institutions are accelerating commercialization efforts, enabling seamless integration of spatial transcriptomics into clinical workflows. These partnerships are driving rapid adoption, positioning spatial transcriptomics as a cornerstone technology for addressing complex biological questions and advancing translational research in a competitive market.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Single-cell Omics Market”

The Global Single-cell Omics Market is segmented into product type, application, end user, regional distribution, and company.

Based on end user, pharmaceutical and biotechnology companies are currently dominating the Global Single-cell Omics Market. These companies are at the forefront of adopting single-cell technologies due to their critical role in drug discovery, precision medicine, and therapeutic development. The ability to analyze individual cells at a genomic, transcriptomic, or proteomic level enables these organizations to gain insights into cellular heterogeneity, disease mechanisms, and therapeutic responses. As a result, pharmaceutical and biotechnology companies are leveraging single-cell omics to identify novel drug targets, optimize clinical trials, and enhance personalized treatment strategies, particularly in areas like cancer, immunology, and neurology. The pharmaceutical sector’s investment in single-cell technologies is propelled by the increasing demand for targeted therapies and the need for more accurate patient stratification. With a growing emphasis on precision medicine, these companies are continuously seeking to integrate advanced single-cell analysis into their R&D pipelines, further solidifying their dominance in the market. 

Based on region, Europe is the second dominating region in the Global Single-cell Omics Market. The region benefits from a strong presence of leading academic and research institutions, as well as major pharmaceutical and biotechnology companies, driving the adoption of single-cell omics technologies. European countries, particularly Germany, the United Kingdom, and France, are heavily invested in advancing genomics, precision medicine, and cancer research, all of which benefit from the insights provided by single-cell analysis. Europe also benefits from favorable regulatory environments and substantial funding for scientific research, which further accelerates the growth of the single-cell omics market. Collaborative initiatives between universities, research organizations, and private companies have fostered an ecosystem conducive to innovation in single-cell technologies. The increasing emphasis on personalized medicine in Europe is encouraging the integration of single-cell omics into clinical practices, particularly in oncology and immunology. With the rise of multi-omics and precision medicine initiatives, the demand for single-cell technologies is expected to grow even further in Europe, maintaining its position as a significant player in the global market.

Major companies operating in Global Single-cell Omics Market are:

• Danaher Corporation
• CYTENA GmbH
• 10x Genomics Inc
• Becton, Dickinson and Company
• Cellenion SASU
• PerkinElmer Inc.
• ANGLE plc
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Mission Bio, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The single-cell omics market is witnessing a growing emphasis on multi-omics approaches, which integrate various omics layers—such as genomics, transcriptomics, proteomics, and metabolomics—at the single-cell level. This holistic strategy provides a comprehensive understanding of cellular function and heterogeneity, surpassing the limitations of single-omics studies. The trend toward multi-omics integration is driven by advancements in high-throughput sequencing technologies and bioinformatics tools capable of handling complex datasets. Researchers are increasingly adopting multi-omics to investigate intricate biological systems, such as immune responses, cancer evolution, and developmental processes. This approach allows for simultaneous analysis of genetic, epigenetic, and metabolic profiles, providing a more nuanced perspective on cellular mechanisms. Pharmaceutical companies are leveraging multi-omics data to accelerate drug discovery and development. By identifying unique cellular signatures, these approaches aid in uncovering novel drug targets and predicting therapeutic responses.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Single-cell Omics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics), By Application (Oncology, Cell Biology, Neurology, Immunology), By End-User (Pharmaceutical & Biotechnology Companies, Academic and Research Organizations, Hospital and Diagnostic Laboratories, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Single-cell Omics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Single-cell Omics Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com